Coronavirus: Everything You Need to Know

Latest Episodes:

COVID Research, Clinical Trials, and the Future of Vaccines May 21, 2021

Show notes

Co-PI of the NIH-funded Leadership Group for the Vaccine and Treatment Evaluation Unit network Dr. Kathleen M. Neuzil, joins Dr. Marc Siegel and explains her work as part of the strategic team evaluating COVID vaccines and therapeutics in the US. As part of the study team who designed the first COVID-19 vaccine trial, she explains how the trials were conducted, the stringent guidelines followed, and the collaboration that helped make the MRNA vaccines so successful.

Looking Back at COVID-19—With a Look to the Future May 19, 2021

Show notes

Former Director of the Centers for Disease Control and Prevention and former administrator for the Agency of Toxic Substances and Disease Registry, Dr. Robert Redfield, joins Dr. Marc Siegel and weighs in on the origins of COVID-19. Hear his thoughts on the platforms used to create COVID vaccines, and the controversial new mask guidelines.

What You Need To Know About Summer Camp 2021 May 18, 2021

Show notes

Child Psychiatrist Dr. Jess Shatkin and his guests discuss what summer camp looks like in 2021. Hear about social distancing and masking considerations, how campers will bunk as cohorts, and the questions parents need to ask to make sure their kids are kept safe.

NIH Director Francis Collins Update May 14, 2021

Show notes

The Director of the National Institutes of Health, Dr. Francis Collins, joins Dr. Marc Seigel and dispels myths about COVID-19's origins, how the COVID vaccines work, and the side effects of the vaccines. And, he offers insight into some of the therapeutics and preventatives that are on the horizon to help with any future viral threats.

White House Update on COVID Vaccine Authorization and Distribution May 13, 2021

Show notes

Chief Science Officer for the White House COVID-19 Response and Former FDA Commissioner, Dr. David Kessler, joins Dr. Marc Siegel and weighs in on the FDA’s decision to authorize the COVID vaccine for children as young as 12. He discusses vaccine distribution and what needs to be done to encourage vaccine compliance.

What You Need to Know about the COVID Vaccine for Children 12 to 16 May 13, 2021

Show notes

Pediatrician Dr. Seema Awatramani and her guests examine the data on the vaccine just approved for children as young as 12. And they answer questions on efficacy, safety, and concerns about adverse reactions.

FDA’s EUA of COVID Vaccine for Children 12 to 16 May 12, 2021

Show notes

Former President of the AAP, Dr. Benard Dreyer, joins Dr. Marc Siegel and reviews the data that led to the FDA’s decision to move forward with Emergency Use Authorization of a COVID vaccine for children as young as 12. Learn how soon young teens and older preteens will be able to raise their sleeves and get vaccinated.

COVID Vaccine Safety Protocols, Global Availability and Rollout May 11, 2021

Show notes

Angela Rasmussen, PhD, research scientist at the Vaccine and Infectious Disease Research Organization – International Vaccine Centre (VIDO-InterVac) joins Dr. Marc Siegel and dispels the misinformation about vaccine efficacy and safety protocols. Hear about the vaccines available globally, and why getting vaccinated is necessary even if you’ve already had COVID.

What You Need To Know About COVID Vaccines for Children May 07, 2021

Show notes

Pediatrician Dr. Benard Dreyer and his guest discuss the progress of the COVID vaccine clinical trials for children under 12. Learn how effective the vaccine is expected to be, if there are any safety concerns, and what a vaccine for children will mean in our battle to overcome this pandemic.

COVID Vaccine Impact on Mammogram Readings, Cancer Care May 06, 2021

Show notes

Dr. Marc Siegel and his guest discuss what considerations are necessary for breast cancer screenings throughout this pandemic. Learn how the vaccine can affect screening results, the difference between a mammogram and an MRI, and why getting back on a regular cancer screening schedule is vital.